Quantum BioPharma

QNTM

Biotechnology · Healthcare

Exchange

NASDAQ

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Quantum BioPharma Ltd. is a small Canadian pharmaceutical company focused on developing drugs for addiction and mental health conditions. Its main programs include treatments targeting alcohol use disorder and other substance dependencies, with patients and healthcare providers as the end customers. The company is in the clinical-stage, meaning it is still testing its drugs and has not yet brought a product to market.

Quantum BioPharma does not currently generate meaningful revenue, which explains the zero gross margin figures. It funds its operations primarily through equity financing, which is common for early-stage drug developers. The company operates mainly in Canada and the United States, but it is very small with a market cap near zero. The key risk here is straightforward: clinical-stage companies frequently fail to get drugs approved, and without a successful trial result or partnership with a larger pharmaceutical company, the business could run out of funding before reaching commercialization.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+84.3% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

11.0%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~17 months

$10M cash & investments

Quarterly Free Cash Flow

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

-21.5%

Weak — -21.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.12

Conservative — low debt load (0.12)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial